Compared to warfarin, all direct oral anticoagulants (DOACs) were associated with fewer cardiovascular events including heart attacks and strokes in a study…

The proportion of out-of-hospital cardiac arrest (OHCA) patients in Sweden who received bystander CPR increased by 27.4 percent over an 18-year period, according to a new…

A new AI software can quickly and accurately determine the manufacturer and model of a cardiac rhythm device from an x-ray, possibly speeding up treatment when the devices fail.

More than 1 million people are implanted with pacemakers,…

A mesh envelope embedded with antibiotics cut the risk of major device-related infections by 40 percent when placed around cardiac implantable electronic devices (CIEDs) like pacemakers and defibrillators, researchers reported in the …

A catheter ablation protocol for atrial fibrillation (AFib) including only “the bare essentials” of the procedure delivered similar outcomes as a more involved strategy featuring pulmonary vein mapping, according to research presented at EHRA…

NEW ORLEANS — An antithrombotic regimen of apixaban plus a P2Y12 inhibitor such as clopidogrel lowered bleeding events and hospitalizations compared to warfarin plus clopidogrel in a cohort of patients with atrial fibrillation (AFib) and a recent…

The Apple Watch’s FDA-cleared electrocardiogram (ECG) feature has already helped some people uncover undiagnosed atrial fibrillation, leading to necessary medical treatment. But cardiologists fear false positives may be the more common occurrence…

A study published Feb. 14 in the American Journal of Cardiology suggests obese patients with atrial fibrillation (AF) fare better in terms of…

Black Medicare beneficiaries with implanted cardiac devices (ICDs) face a lower risk of atrial fibrillation (AF) than their white counterparts, despite a higher overall burden of vascular risk factors and a greater risk of stroke,…

His-optimized cardiac resynchronization therapy successfully narrowed QRS duration, improved left ventricular (LV) ejection fraction and heightened functionality in 27 patients with advanced heart failure (HF), according to a study…

The lifetime cumulative risk of sudden cardiac death (SCD) is much higher in black patients than in whites, according to an analysis of the Atherosclerosis Risk in Communities (ARIC) Study published in…

Researchers from the Thayer School of Engineering at Dartmouth College have developed a dime-sized innovation they claim converts the heart’s energy into electricity to power implantable devices like pacemakers and defibrillators,…

Atrial fibrillation (AF) is rare during dobutamine stress echocardiography (DSE), a routine exam for assessing coronary ischemia, but elderly patients and those with a history of paroxysmal AF are at an increased risk for arrhythmia…

A Journal of the American Heart Association study focused on the programming safety of cardiac implantable electronic devices (CIEDs) suggests the…

Stryker announced on Feb. 1 it is voluntarily recalling certain Lifepak 15 monitor/defibrillators over an issue which may cause the devices to lock up and not deliver potentially life…

Patients who experienced tachycardia within one year of being diagnosed with cancer carried higher mortality rates up to a decade later—even after adjusting for clinical characteristics and medication use—according to research presented Jan. 25…

Breast cancer patients under 60 years old are nearly twice as likely as their healthy counterparts to develop both short- and long-term atrial fibrillation (AF), researchers reported Jan. 29 in Heart Rhythm.

…

Non-vitamin K oral anticoagulants (NOACs) including dabigatran, rivaroxaban, apixaban and edoxaban have replaced warfarin as the preferred treatment for reducing stroke risk in patients with atrial fibrillation, according to updated…

Royal Philips and the American Heart Association are collaborating for a new program devoted to increasing survival rates in patients who experience sudden cardiac arrest (SCA), the organizations announced Jan. 23.

The…

Leadless pacemakers are a viable alternative to conventional pacemakers in patients with a history of device infection and lead extraction, researchers reported in the January edition of…

Abbott on Jan. 21 announced the FDA approval of one of its atrial fibrillation (AFib) ablation catheters, the TactiCath Contact Force Ablation Catheter.

The sensor-enabled catheter “delivers more precise images of the heart overlaid with…